Search Within

Ellen Marlese Basu

  1. "General Oncology Service"
Formats
  1. Journal Article (12)
  2. Meeting Abstract (5)
Groups
  1. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (17)
  2. GSK Faculty (17)
  3. General Oncology Service (17)
  4. Neuroblastoma Service (17)
  5. Pediatrics, Department of (17)
  6. Tow Center for Developmental Oncology (TCDO) (17)

More Groups

People
  1. Nai-Kong Cheung (17)
  2. Shakeel Modak (17)
  3. Brian Kushner (16)
  4. Stephen Roberts (15)
  5. Irene Cheung (12)
  6. Audrey Mauguen (7)

More People

Years
  1. 2025 (1)
  2. 2024 (2)
  3. 2023 (1)
  4. 2022 (2)
  5. 2021 (2)
  6. 2020 (1)

More Years

Publications
  1. Cancer Research (2)
  2. JAMA Oncology (2)
  3. Journal of Clinical Oncology (2)
  4. OncoImmunology (2)
  5. Oncotarget (2)
  6. Pediatric Blood and Cancer (2)

More Publications

Publishers
  1. American Association for Cancer Research (3)
  2. American Medical Association (2)
  3. American Society of Clinical Oncology (2)
  4. Impact Journals (2)
  5. Landes Bioscience (2)
  6. Wiley Periodicals, Inc (2)

More Publishers

Results (17)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Adoptive immunotherapy with haploidentical natural killer cells and Anti-GD2 monoclonal antibody m3F8 for resistant neuroblastoma: Results of a phase I study
    Journal Article

    Modak, S.; Le Luduec, J. B.; Cheung, I. Y.; Goldman, D. A.; Ostrovnaya, I.; Doubrovina, E.; Basu, E.; Kushner, B. H.; Kramer, K.; Roberts, S. S.; more...
    OncoImmunology (2018)

    Fulltext@MSK | Save
  • MYCN-amplified stage 2/3 neuroblastoma: Excellent survival in the era of anti-G(D2) immunotherapy
    Journal Article

    Kushner, B. H.; LaQuaglia, M. P.; Modak, S.; Wolden, S. L.; Basu, E. M.; Roberts, S. S.; Kramer, K.; Yataghene, K.; Cheung, I. Y.; Cheung, N. V.
    Oncotarget (2017)

    Fulltext@MSK | Save
  • Phase I trial of anti-GD2 monoclonal antibody hu3F8 plus GM-CSF: Impact of body weight, immunogenicity and anti-GD2 response on pharmacokinetics and survival
    Journal Article

    Cheung, I. Y.; Kushner, B. H.; Modak, S.; Basu, E. M.; Roberts, S. S.; Cheung, N. K. V.
    OncoImmunology (2017)

    Fulltext@MSK | Save
  • Event-free survival (EFS) and overall survival (OS) of MYCN-amplified stage 2/3 neuroblastoma with or without autologous stem-cell transplantation (ASCT)
    Meeting Abstract

    Kushner, B. H.; Modak, S.; LaQuaglia, M. P.; Wolden, S. L.; Basu, E. M.; Roberts, S. S.; Kramer, K.; Cheung, I. Y.; Cheung, N. K. V.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Lack of survival advantage with autologous stem-cell transplantation in high-risk neuroblastoma consolidated by anti-GD2 immunotherapy and isotretinoin
    Journal Article

    Kushner, B. H.; Ostrovnaya, I.; Cheung, I. Y.; Kuk, D.; Modak, S.; Kramer, K.; Roberts, S. S.; Basu, E. M.; Yataghene, K.; Cheung, N. K. V.
    Oncotarget (2016)

    Fulltext@MSK | Save
  • Predisposing factors for short stature in long-term survivors of high-risk neuroblastoma
    Meeting Abstract

    Yang, J. C.; Friedman, D. N.; Woo, K. M.; Kushner, B. H.; Cheung, N. K. V.; Modak, S.; Roberts, S. S.; Basu, E. M.; Wolden, S. L.
    International Journal of Radiation Oncology, Biology, Physics (2015)

    Fulltext@MSK | Save
  • Osteochondroma in long-term survivors of high-risk neuroblastoma
    Journal Article

    Kushner, B. H.; Roberts, S. S.; Friedman, D. N.; Kuk, D.; Ostrovnaya, I.; Modak, S.; Kramer, K.; Basu, E. M.; Cheung, N. K. V.
    Cancer (2015)

    Fulltext@MSK | Save